X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (192501) 192501
Book Review (30889) 30889
Publication (16442) 16442
Newsletter (7644) 7644
Newspaper Article (1881) 1881
Book Chapter (1183) 1183
Conference Proceeding (629) 629
Magazine Article (504) 504
Book / eBook (322) 322
Transcript (159) 159
Dissertation (100) 100
Trade Publication Article (72) 72
Government Document (53) 53
Reference (33) 33
Data Set (24) 24
Report (15) 15
Web Resource (13) 13
Paper (7) 7
Journal / eJournal (4) 4
Streaming Video (4) 4
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (168920) 168920
humans (116251) 116251
animals (86707) 86707
female (72639) 72639
male (61991) 61991
mice (45918) 45918
immunology (40068) 40068
antibodies (38312) 38312
adult (32495) 32495
middle aged (31184) 31184
monoclonal antibodies (21292) 21292
aged (21114) 21114
oncology (20622) 20622
abridged index medicus (18729) 18729
antibodies, monoclonal - therapeutic use (17618) 17618
research (17418) 17418
treatment outcome (17099) 17099
cancer (16169) 16169
antibodies, monoclonal - administration & dosage (15438) 15438
immunization (15106) 15106
health aspects (14955) 14955
vaccination (14776) 14776
rats (14584) 14584
analysis (14424) 14424
vaccines (14296) 14296
mice, inbred balb c (13985) 13985
medicine, research & experimental (13840) 13840
pharmacology & pharmacy (13760) 13760
care and treatment (13681) 13681
proteins (13152) 13152
antigens (12558) 12558
adolescent (12205) 12205
viral antibodies (12107) 12107
therapy (11535) 11535
expression (11416) 11416
monoclonal-antibody (11392) 11392
immunotherapy (11256) 11256
infectious diseases (11198) 11198
time factors (11182) 11182
enzyme-linked immunosorbent assay (10147) 10147
antibody (9982) 9982
infection (9935) 9935
disease models, animal (9832) 9832
mice, inbred c57bl (9514) 9514
child (9332) 9332
hematology (9285) 9285
antibodies, monoclonal, humanized (8897) 8897
immunoglobulins (8589) 8589
drug therapy (8540) 8540
infections (8492) 8492
disease (8482) 8482
medical research (8298) 8298
article (8288) 8288
antibodies, viral - blood (8219) 8219
antibody formation (8098) 8098
microbiology (7915) 7915
chemotherapy (7840) 7840
immune response (7784) 7784
cells (7585) 7585
medicine (7580) 7580
antineoplastic combined chemotherapy protocols - therapeutic use (7563) 7563
medicine & public health (7550) 7550
research article (7539) 7539
fluorescent antibody technique (7524) 7524
multidisciplinary sciences (7502) 7502
immunogenicity (7375) 7375
risk factors (7228) 7228
monoclonal-antibodies (7207) 7207
clinical trials (7203) 7203
rituximab (7162) 7162
immunity (7051) 7051
viruses (7050) 7050
antibodies, monoclonal - adverse effects (7016) 7016
antibodies, monoclonal - immunology (6973) 6973
young adult (6936) 6936
in-vivo (6931) 6931
cell biology (6928) 6928
aged, 80 and over (6862) 6862
vaccine (6805) 6805
inflammation (6706) 6706
infant (6644) 6644
biochemistry & molecular biology (6635) 6635
safety (6606) 6606
transplantation (6559) 6559
child, preschool (6542) 6542
t cells (6528) 6528
veterinary sciences (6524) 6524
t-lymphocytes - immunology (6511) 6511
efficacy (6494) 6494
cytokines (6454) 6454
neurosciences (6277) 6277
lymphocytes (6259) 6259
bevacizumab (6218) 6218
tumors (6203) 6203
studies (6129) 6129
physiological aspects (6122) 6122
children (6111) 6111
immunohistochemistry (6095) 6095
dose-response relationship, drug (6062) 6062
virology (6009) 6009
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (221) 221
Online Resources - Online (14) 14
UofT at Mississauga - Stacks (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
UofT at Scarborough - Stacks (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
UTL at Downsview - May be requested (8) 8
Engineering & Comp. Sci. - Stacks (6) 6
Robarts - Stacks (6) 6
New College (Ivey) - Stacks (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (4) 4
Trinity College (John W Graham) - Stacks (4) 4
Earth Sciences (Noranda) - Stacks (3) 3
Gerstein Science - Circulation Desk (3) 3
Chemistry (A D Allen) - Stacks (2) 2
University College (Laidlaw) - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Humber River Regional Hospital - Church Stacks (1) 1
Law (Bora Laskin) - Reserve desk (1) 1
Mt Sinai Hospital - Pathology (1) 1
Regis College - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Victoria University E.J. Pratt - Northrop Frye (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (195822) 195822
Russian (1879) 1879
Japanese (1458) 1458
German (1427) 1427
French (1057) 1057
Chinese (502) 502
Spanish (491) 491
Italian (271) 271
Polish (241) 241
Czech (127) 127
Hungarian (106) 106
Portuguese (73) 73
Bulgarian (63) 63
Danish (56) 56
Swedish (52) 52
Korean (45) 45
Dutch (41) 41
Ukrainian (41) 41
Romanian (37) 37
Slovak (32) 32
Turkish (27) 27
Norwegian (26) 26
Croatian (19) 19
Finnish (12) 12
Hebrew (12) 12
Serbian (11) 11
Lithuanian (4) 4
Bosnian (2) 2
Arabic (1) 1
Greek (1) 1
Icelandic (1) 1
Persian (1) 1
Slovenian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Index Medicus | Abridged Index Medicus | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
Circulation, ISSN 0009-7322, 01/2014, Volume 129, Issue 2, pp. 234 - 243
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 14, pp. 1277 - 1290
Journal Article
Circulation (Baltimore), ISSN 0009-7322, 12/2010, Volume 122, Issue 25, pp. 2709 - 2717
Journal Article
The Lancet, ISSN 0140-6736, 08/2001, Volume 358, Issue 9282, pp. 605 - 613
Current fibrinolytic therapies fail to achieve optimum reperfusion in many patients. Low-molecular-weight heparins and platelet glycoprotein IIb/IIIa... 
MEDICINE, GENERAL & INTERNAL | THROMBOLYSIS | Recurrence | Humans | Middle Aged | Heparin - administration & dosage | Male | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Chi-Square Distribution | Enoxaparin - administration & dosage | Immunoglobulin Fab Fragments - administration & dosage | Injections | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Survival Analysis | Female | Aged | Fibrinolytic Agents - administration & dosage | Drug Therapy, Combination | Dosage and administration | Thrombolytic drugs | Research | Tenecteplase | Drug therapy | Heart attack | Prevention | Evaluation | Ischemia | Enoxaparin | Reperfusion (Physiology) | Drug therapy, Combination | Heparin | Health aspects | Clinical trials | Heart attacks | Myocardial infarction | Coagulation | Hemorrhage | Bleeding | Infusion | Randomization | Reperfusion | Motivation | Blood platelets | Safety | Heparins | Anticoagulants | Stroke | Effectiveness | Complications | Mortality | Glycoprotein | Pharmacology | Patients | Trauma | Molecular chains | Studies | Fibrin | Monoclonal antibodies | Infarction | Index Medicus | Abridged Index Medicus | Heparin/administration & dosage | Medical and Health Sciences | Medicin och hälsovetenskap | Platelet Aggregation Inhibitors/administration & dosage | MEDICINE | Antibodies; Monoclonal/administration & dosage | Myocardial Infarction/drug therapy | Enoxaparin/administration & dosage | Tissue Plasminogen Activator/administration & dosage | Fibrinolytic Agents/administration & dosage | MEDICIN | Immunoglobulins; Fab/administration & dosage | Drug Therapy; Combination | Research Support; Non-U.S. Gov't
Journal Article
The Lancet Oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
The prognosis of young patients with diffuse large B-cell lymphoma at high risk (age-adjusted International Prognostic Index [aa-IPI] score 2 or 3) treated... 
CLINICAL-PRACTICE GUIDELINES | SURVIVAL | SUPPORT | IMPACT | CONSOLIDATION | RESPONSE CRITERIA | ONCOLOGY | R-CHOP | NON-HODGKIN-LYMPHOMA | ELDERLY-PATIENTS | MEGACHOEP | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Transplantation, Autologous | Consolidation Chemotherapy | Cyclophosphamide - adverse effects | Lymphoma, Large B-Cell, Diffuse - therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Hematologic Diseases - chemically induced | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Risk Factors | Etoposide - administration & dosage | Survival Rate | Cytarabine - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Intention to Treat Analysis | Vincristine - adverse effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Carmustine - administration & dosage | Stem Cell Transplantation - adverse effects | Stem cells | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2015, Volume 112, Issue 2, pp. E156 - E165
Current treatments to control pathological or unwanted immune responses often use broadly immunosuppressive drugs. New approaches to induce antigen-specific... 
Nanoparticles | Rapamycin | Anti-drug antibodies | Immune tolerance | Immunotherapy | THERAPEUTICS | anti-drug antibodies | IMMUNITY | TOLEROGENIC DENDRITIC CELLS | RISK-FACTORS | MULTIDISCIPLINARY SCIENCES | FACTOR-VIII | MECHANISMS | RESPONSES | immune tolerance | IMMUNOGENICITY | nanoparticles | UNRESPONSIVENESS | immunotherapy | rapamycin | Factor VIII - immunology | Oligodeoxyribonucleotides - administration & dosage | Nanoparticles - chemistry | Ovalbumin - immunology | Immunosuppression - methods | Nanocapsules - administration & dosage | Humans | Encephalomyelitis, Autoimmune, Experimental - immunology | Hypersensitivity, Delayed - immunology | Nanocapsules - chemistry | Peptides - administration & dosage | Antigens - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Immunity, Humoral | Peptide Fragments - immunology | Proteins - administration & dosage | Female | Immunosuppressive Agents - administration & dosage | Disease Models, Animal | Lactic Acid - chemistry | Peptides - chemistry | Hemophilia A - immunology | Peptide Fragments - administration & dosage | Peptides - immunology | Immune Tolerance | Hemophilia A - therapy | Hypersensitivity, Delayed - therapy | Antigens - chemistry | Proteins - immunology | Encephalomyelitis, Autoimmune, Experimental - therapy | Sirolimus - administration & dosage | Animals | Ovalbumin - administration & dosage | Recombinant Proteins - immunology | Polyglycolic Acid - chemistry | Encephalomyelitis, Autoimmune, Experimental - prevention & control | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Hemocyanins - administration & dosage | Proteins - chemistry | Antigens | Usage | Research | Health aspects | Immunological tolerance | Immunological research | Immunology | Polymers | Chemical synthesis | Immune system | Index Medicus | Biological Sciences | PNAS Plus
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2011, Volume 22, Issue 3, pp. 664 - 670
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 15, pp. 1408 - 1416
A dose-intense infusional chemotherapy program plus rituximab had a high degree of efficacy in patients with primary mediastinal B-cell lymphoma, which is... 
MEDICINE, GENERAL & INTERNAL | AMPLIFICATION | MANAGEMENT | EFFICACY | DOXORUBICIN | SCLEROSIS | CLASSICAL HODGKIN LYMPHOMA | RADIOTHERAPY | EXPRESSION | GERMINAL-CENTER | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Filgrastim | Dose-Response Relationship, Drug | Young Adult | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Kaplan-Meier Estimate | Rituximab | Stroke Volume - drug effects | Etoposide - administration & dosage | Recombinant Proteins - administration & dosage | Disease-Free Survival | Vincristine - adverse effects | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Granulocyte Colony-Stimulating Factor - administration & dosage | Drugs | Dose-response relationship (Biochemistry) | Usage | Cyclophosphamide | Patient outcomes | Dosage and administration | Lymphomas | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Doxorubicin | Medical research | Nuclear magnetic resonance--NMR | Disease | Review boards | Genes | Etoposide | Prednisone | Radiation therapy